HyperBio Therapeutics ApS Financials, key figures and credit report
Gross profit -74.5 kDKK FY 2023 +99.1% vs 2022
EBIT -74.5 kDKK FY 2023 +99.1% vs 2022
Net debt - 454.1 kDKK FY 2023 -113.5% vs 2022
Quick ratio 1.1 FY 2023 +0.2 vs 2022
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -5 571.12 | -12 881.90 | -8 628.93 | -74.48 |
| Employee benefit expenses | -40.00 | -60.00 | -55.00 | |
| EBIT | -5 611.12 | -12 941.90 | -8 683.93 | -74.48 |
| Other financial income | 6.96 | 7.04 | 16.54 | 155.20 |
| Other financial expenses | -27.35 | - 486.05 | -1 338.46 | -1 330.82 |
| Pre-tax profit | -5 631.52 | -13 420.91 | -10 005.85 | -1 250.10 |
| Income taxes | 1 573.29 | 2 808.04 | 2 349.49 | 277.36 |
| Net earnings | -4 058.23 | -10 612.87 | -7 656.37 | - 972.75 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 1 573.29 | 3 089.55 | 2 313.43 | 277.36 |
| Prepayments and accrued income | 3.28 | |||
| Current other receivables | 39.84 | 67.00 | 135.69 | 12.39 |
| Short term receivables total | 1 616.40 | 3 156.54 | 2 449.12 | 289.74 |
| Cash and bank deposits | 10 419.68 | 19 670.96 | 13 222.62 | 14 364.28 |
| Cash and cash equivalents | 10 419.68 | 19 670.96 | 13 222.62 | 14 364.28 |
| Balance sheet total (assets) | 12 036.08 | 22 827.50 | 15 671.74 | 14 654.03 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 48.00 |
| Retained earnings | 15 000.00 | 15 941.77 | 5 328.90 | 1 664.53 |
| Profit of the financial year | -4 058.23 | -10 612.87 | -7 656.37 | - 972.75 |
| Shareholders equity total | 10 981.77 | 5 368.90 | -2 287.47 | 739.78 |
| Non-current loans from credit institutions | 15 355.07 | |||
| Non-current liabilities total | 15 355.07 | |||
| Current loans from credit institutions | 0.99 | 0.57 | ||
| Current trade creditors | 1 051.11 | 2 100.07 | 1 375.17 | 4.09 |
| Current owed to group member | 16 583.47 | 13 910.15 | ||
| Other non-interest bearing current liabilities | 3.20 | 2.47 | ||
| Current liabilities total | 1 054.31 | 2 103.53 | 17 959.21 | 13 914.24 |
| Balance sheet total (liabilities) | 12 036.08 | 22 827.50 | 15 671.74 | 14 654.03 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated